XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.23.2

Financial Instruments | 6 Months Ended
--- | ---
Jun. 17, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Financial Instruments | Financial Instruments We are exposed to market risks arising from adverse changes in: •commodity prices, affecting the cost of our raw materials and energy; •foreign exchange rates and currency restrictions; and •interest rates. There have been no material changes during the 24 weeks ended June 17, 2023 with respect to our risk management policies or strategies and valuation techniques used in measuring the fair value of the financial assets or liabilities disclosed in Note 9 to our consolidated financial statements in our 2022 Form 10-K. Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of June 17, 2023 was $203 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of June 17, 2023. The notional amounts of our financial instruments used to hedge the above risks as of June 17, 2023 and December 31, 2022 are as follows:
| Notional Amounts(a)
| 6/17/2023 |  | 12/31/2022
Commodity | $ | 1.7 |  |  | $ | 1.8 |
Foreign exchange | $ | 2.8 |  |  | $ | 3.0 |
Interest rate | $ | 1.3 |  |  | $ | 1.3 |
Net investment (b) | $ | 3.0 |  |  | $ | 2.9 |
(a)In billions. (b)The total notional of our net investment hedge consists of non-derivative debt instruments. As of June 17, 2023, approximately 10% of total debt, after the impact of the related interest rate derivative instruments, was subject to variable rates, compared to 1% as of December 31, 2022. Debt Securities Available-for-Sale Investments in available-for-sale debt securities are reported at fair value. Changes in the fair value of available-for-sale debt securities are generally recognized in accumulated other comprehensive loss within common shareholders’ equity. Changes in the fair value of available-for-sale debt securities impact earnings only when such securities are sold, or an allowance for expected credit losses or impairment is recognized. We regularly evaluate our investment portfolio for expected credit losses and impairment. In making this judgment, we evaluate, among other things, the extent to which the fair value of a debt security is less than its amortized cost; the financial condition of the issuer, including the credit quality, and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the debt security before recovery of its amortized cost basis. Our assessment of whether a debt security has a credit loss or is impaired could change in the future due to new developments or changes in assumptions related to any particular debt security. There were no unrealized gains and losses on our investments as of June 17, 2023. Impairment charges related to our investments for the 24 weeks ended June 17, 2023 were not material. TBG Investment In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners, while retaining a 39% noncontrolling interest in TBG, operating across North America and Europe. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). See Note 12 for further information. In the 12 and 24 weeks ended June 17, 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $113 million ($86 million after-tax or $0.06 per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy. Fair Value Measurements The fair values of our financial assets and liabilities as of June 17, 2023 and December 31, 2022 are categorized as follows:
|  |  | 6/17/2023 |  | 12/31/2022
| Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)
Available-for-sale debt securities (b) | 2 |  | $ | 574 |  |  | $ | — |  |  | $ | 660 |  |  | $ | — |
Index funds (c) | 1 |  | $ | 273 |  |  | $ | — |  |  | $ | 257 |  |  | $ | — |
Prepaid forward contracts (d) | 2 |  | $ | 14 |  |  | $ | — |  |  | $ | 14 |  |  | $ | — |
Deferred compensation (e) | 2 |  | $ | — |  |  | $ | 447 |  |  | $ | — |  |  | $ | 434 |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |  |
Foreign exchange (f) | 2 |  | $ | 5 |  |  | $ | 43 |  |  | $ | 24 |  |  | $ | 22 |
Interest rate (f) | 2 |  | 6 |  |  | 144 |  |  | — |  |  | 164 |
Commodity (g) | 2 |  | — |  |  | 58 |  |  | 2 |  |  | 60 |
|  |  | $ | 11 |  |  | $ | 245 |  |  | $ | 26 |  |  | $ | 246 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |  |
Foreign exchange (f) | 2 |  | $ | 9 |  |  | $ | 37 |  |  | $ | 21 |  |  | $ | 21 |
Commodity (g) | 2 |  | 7 |  |  | 33 |  |  | 11 |  |  | 51 |
|  |  | $ | 16 |  |  | $ | 70 |  |  | $ | 32 |  |  | $ | 72 |
Total derivatives at fair value (h) |  |  | $ | 27 |  |  | $ | 315 |  |  | $ | 58 |  |  | $ | 318 |
Total |  |  | $ | 888 |  |  | $ | 762 |  |  | $ | 989 |  |  | $ | 752 |
(a)Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets) and Level 2 (significant other observable inputs) in both years. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities. (b)Primarily related to our investment in Celsius Holdings, Inc. convertible preferred stock. The fair value of our investment approximates the transaction price and any accrued dividends, as well as the amortized cost. As of June 17, 2023, $16 million and $558 million were classified as short-term investments and other assets, respectively. As of December 31, 2022, $3 million, $104 million and $553 million were classified as cash equivalents, short-term investments and other assets, respectively. (c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (d)Based primarily on the price of our common stock. (e)Based on the fair value of investments corresponding to employees’ investment elections. (f)Based on recently reported market transactions of spot and forward rates. (g)Primarily based on recently reported market transactions of swap arrangements. (h)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of June 17, 2023 and December 31, 2022 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table. The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of June 17, 2023 and December 31, 2022 was $40 billion and $35 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs. Losses/(gains) on our cash flow and net investment hedges are categorized as follows:
| 12 Weeks Ended
| Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
| 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022
Foreign exchange | $ | 43 |  |  | $ | 26 |  |  | $ | 14 |  |  | $ | (17) |
Interest rate | (37) |  |  | 82 |  |  | (30) |  |  | 61 |
Commodity | (15) |  |  | (1) |  |  | 28 |  |  | (74) |
Net investment | 71 |  |  | (88) |  |  | — |  |  | — |
Total | $ | 62 |  |  | $ | 19 |  |  | $ | 12 |  |  | $ | (30) |
|  |  |  |  | 24 Weeks Ended
|  |  | Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
|  |  |  |  | 6/17/2023 |  | 6/11/2022 |  | 6/17/2023 |  | 6/11/2022
Foreign exchange |  |  |  |  | $ | 59 |  |  | $ | 18 |  |  | $ | 15 |  |  | $ | (21) |
Interest rate |  |  |  |  | (26) |  |  | 79 |  |  | (27) |  |  | 81 |
Commodity |  |  |  |  | 50 |  |  | (190) |  |  | 37 |  |  | (152) |
Net investment |  |  |  |  | 108 |  |  | (139) |  |  | — |  |  | — |
Total |  |  |  |  | $ | 191 |  |  | $ | (232) |  |  | $ | 25 |  |  | $ | (92) |
(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Interest rate derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information. Based on current market conditions, we expect to reclassify net losses of $107 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months. Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:
| 12 Weeks Ended
| 6/17/2023 |  | 6/11/2022
| Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total
Foreign exchange | $ | — |  |  | $ | 44 |  |  | $ | 44 |  |  | $ | (14) |  |  | $ | 35 |  |  | $ | 21 |
Commodity | 5 |  |  | 3 |  |  | 8 |  |  | (60) |  |  | (121) |  |  | (181) |
Total | $ | 5 |  |  | $ | 47 |  |  | $ | 52 |  |  | $ | (74) |  |  | $ | (86) |  |  | $ | (160) |
| 24 Weeks Ended
| 6/17/2023 |  | 6/11/2022
| Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total
Foreign exchange | $ | (1) |  |  | $ | 39 |  |  | $ | 38 |  |  | $ | (3) |  |  | $ | 8 |  |  | $ | 5 |
Commodity | 36 |  |  | 53 |  |  | 89 |  |  | (134) |  |  | (213) |  |  | (347) |
Total | $ | 35 |  |  | $ | 92 |  |  | $ | 127 |  |  | $ | (137) |  |  | $ | (205) |  |  | $ | (342) |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//815/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//820/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration